Question 1

Which Wall Street gurus hold Corcept Therapeutics Inc (CORT)?

Accepted Answer

Per the latest SEC 13F filings, 17 Wall Street gurus hold CORT. Top holders include 짐 사이먼스 (유산), 조셉 에델만, 데이비드 시겔, with a combined position value of about $1.16B.

Question 2

What sector does Corcept Therapeutics Inc belong to?

Accepted Answer

Corcept Therapeutics Inc (CORT) is in the Pharmaceuticals sector / Pharmaceuticals industry, listed on NASDAQ NMS - GLOBAL MARKET.

Question 3

What are the key financial metrics for Corcept Therapeutics Inc?

Accepted Answer

Key metrics for Corcept Therapeutics Inc (CORT): P/E 200.1x, EPS $0.35, Beta 0.49. Live price and chart are at the top of the page.

Question 4

What is a 13F report?

Accepted Answer

A 13F is a quarterly filing institutional investors submit to the US Securities and Exchange Commission (SEC) disclosing their equity holdings. It is mandatory for managers with at least $100M in AUM and must be filed within 45 days of the quarter end.

#	Investor	Weight	Shares	Value	Activity
1	Jim Simons (Estate) Renaissance Technologies LLC	0.36%	5,682,783	$229.07M	HOLD
2	Joseph Edelman Perceptive Advisors LLC	0.04%	50,000	$2.02M	HOLD
3	Two Sigma Two Sigma Investments LP	0.03%	945,884	$38.13M	HOLD
4	David E. Shaw D.E. Shaw & Co LP	0.03%	1,181,348	$47.62M	HOLD
5	Israel Englander Millennium Management LLC	0.01%	558,747	$22.52M	HOLD
6	BlackRock BlackRock Inc	0.01%	12,151,276	$489.82M	HOLD
7	Cliff Asness AQR Capital Management LLC	0.01%	406,205	$15.87M	HOLD
8	Ray Dalio Bridgewater Associates LP	0.01%	38,422	$1.55M	HOLD
9	Fidelity (FMR) Fidelity Management & Research	0.01%	3,190,192	$128.60M	HOLD
10	State Street State Street Global Advisors	0.00%	3,200,946	$129.03M	HOLD
11	Goldman Sachs Goldman Sachs Asset Management	0.00%	725,822	$29.26M	HOLD
12	Steve Cohen Point72 Asset Management LP	0.00%	56,181	$2.26M	HOLD
13	Joel Greenblatt Gotham Asset Management LLC	0.00%	17,918	$722,275	HOLD
14	Paul Tudor Jones Tudor Investment Corp	0.00%	25,916	$1.04M	HOLD
15	Ken Griffin Citadel Advisors LLC	0.00%	254,220	$10.25M	HOLD
16	JPMorgan Chase JPMorgan Asset Management	0.00%	200,953	$7.66M	HOLD
17	T. Rowe Price T. Rowe Price Associates	0.00%	86,590	$3.49M	HOLD

Insider	Title	Type	Shares	Value	Date
Guyer William	Chief Development Officer	SELL	952	$0.1M	7/7/2026
Guyer William	Chief Development Officer	SELL	19,048	$1.8M	7/7/2026
Guyer William	Chief Development Officer	SELL	20,000	$0.4M	7/7/2026
Robb Gary Charles	Chief Business Officer	SELL	600	--	5/27/2026
Maduck Sean	See Remarks	SELL	2,801	$0.2M	7/1/2026
Maduck Sean	See Remarks	SELL	25,000	$0.2M	7/1/2026
Maduck Sean	See Remarks	SELL	11,024	$1.0M	7/1/2026
Maduck Sean	See Remarks	SELL	11,175	$1.0M	7/1/2026
MAHONEY DAVID L	Director	SELL	20,000	$1.7M	6/17/2026
WILSON JAMES N	Director	SELL	4,177	$0.3M	6/16/2026

Corcept Therapeutics Inc

Holders (17)

Insider Trades (17)